Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Sep 25, 2026 · 10-K · 87 days after period end · 0001493152-26-044373
derived · Computed from the longer spans the company filed.
| Metric | Q4 2026dderived from reported figures | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$4.57M | -$4.07M | -$358.58K | -$748.04K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Sep 25, 2026 · 87 d after period end
